EGFR and cholangiocarcinoma: Genistein was reported to promote cell death in intrahepatic CCA cell lines, HuCCA-1 and RNCCA-1, via inhibiting survival signaling of epidermal growth factor receptor (EGFR), AKT, and the mitogen-activated protein kinase (MAPK) cascade [47].